[Press Release] PCMO and Chosun University Complete 3-Week Vaccine Training Program

  • ER
  • 2025.09.04

- August 11–29, intensive three-week course concluded successfully... Comprehensive training from production to quality control



▲ Professor Kyu-Min Kim of Chosun University with 16 graduates of the program


PCMO (Director: Cho Min, hereinafter “the Center”) announced that it successfully completed a three-week Vaccine Training Program for 16 students from Chosun University’s Department of Biomedical Sciences and related majors, held from August 11 to 29.


The program was designed in accordance with the Good Manufacturing Practice (GMP) standards set by the Ministry of Food and Drug Safety, combining theory and practical training for better understanding. The curriculum covered ▲Basic GMP training ▲Validation ▲Biopharmaceutical cultivation and purification ▲Utilities (facility management) ▲Quality Control (QC) ▲Virtual Reality (VR)-based cultivation and purification practice. Each session was delivered by experts with extensive field experience, providing participants with practical and industry-relevant insights.


Since 2023, the Center and Chosun University have been jointly operating this training curriculum, producing more than 80 graduates to date. More than half of the participants have successfully secured employment in the pharmaceutical and biotechnology sectors, with many reporting that the Center’s training was a significant factor in their career development.




▲ Education Center of the PCMO



Meanwhile, supported by the Ministry of Trade, Industry and Energy and Hwasun County, the Center is preparing to open a state-of-the-art GMP Training Facility in July 2025 — the largest of its kind in the Gwangju–Jeonnam region.


The new training center will be equipped with advanced pharmaceutical production systems, including a 50L bioreactor, autoclave, continuous centrifuge, as well as analytical instruments such as HPLC and LC-MS. It will also support microbiological testing, environmental monitoring, and QC training. The Center aims to train more than 900 professionals by 2026 and will collaborate with the WHO Global Bio Hwasun Campus to strengthen domestic and international vaccine capabilities.